Recently, it was ascertained that lncRNA-SLC7A11-AS1 promotes cancer stemness via scavenging reactive oxygen species (ROS) and that the silencing of lncRNA-SLC7A11-AS1 re-sensitizes resistant cells to gemcitabine [197]. This evidence concerns the gene SLC7A11 and cancer.